Research Of Enterprise Merger And Acquisition (M & A) And Medicine Industrial Structure Being Optimized

Readjustment of the industrial structure and upgrade level of industrialization and the improvement of a country's economic development is the key to motivation and signs. At present, China is in a critical period of restructuring, Advanced industrial structure is the key to the role of market mechanisms in resource allocation to the basic role, in particular, to establish a market-based allocation of capital formation and the mechanism to adjust the unreasonable industrial structure, product structure and the organizational structure of enterprises, and promote the optimization and upgrading of industrial structure, improve the state's industrial competitiveness.M & A is the enterprises replacement and upgrading of industries an important way of improving industrial concentration, achieve economies of scale at the same time, promote the optimization of the organizational structure and the rational allocation of resources. At present, mergers and acquisitions of enterprises as a strategic and industrial optimization methods and measures, China's economic development is play -ing an increaseingly active role.As to the relationship between human health life industry, the pharmaceutical industry of the industrial chain, relate to high-level, Fushemian wide. Entered the 21st century global pharmaceutical market has entered a new period of the group army operations on the international transnational pharmaceutical companies with products, capital, technology, human resources, management, output and effective joint merger is to achieve a low-cost expansion and capital goods expansion strategy. China's pharmaceutical industry and a significantly lower concentration, and the international pharmaceutical industry is still lagging far behind, and contend with transnational corporations from the point of view of China's pharmaceutical industry has been in the international pharmaceutical value chain as a low-end varieties in the role of producer, It is precisely because of the low level of industry, technology content less, which led to the Chinese pharmaceutical enterprises redundant construction and disorderly competition and trigger environmental protection, such as the lack of competitiveness of a range of issues. Faced with this challenge, China's pharmaceutical industry must stand on the high degree of industrialization, speed up the readjust- ment of the industrial structure medicine to large-scale enterprises to enhance the economic strength and competitive strength and to increase market concentration to the coverage.This paper studies the system for optimization of the industrial structure merger on the basis of theory, pointing out that China's current medical problems that exist in the industrial structure and Countermeasures, by analyzing three typical pharmaceutical merger case, the specific study of the cunent reorganization as a tool to deal to optimize the industrial structure medicine for the purpose of improving the pharmaceutical industry concentration and rational integration resources, sustainable access to economies of scale, and enhancing our pharmaceutical industry in the global competitiveness of the pharmaceutical industry the feasibility of, and briefly describeed the pharmaceutical industry after the merger integration ways to ensure that the maximum effect of mergers and acquisitions.